August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Incidence and Survival Outcomes of Breast Cancer Subtypes in the United States
Jun 5, 2025, 10:49

Incidence and Survival Outcomes of Breast Cancer Subtypes in the United States

Sakditad “Tew” Saowapa, Oncologist at UI Holden Comprehensive Cancer Center, shared a post on X:

Proud to present our work at the 2025 ASCO.

Annual Meeting, now in JCO!

Incidence and survival outcomes of breast cancer subtypes in the United States.

  • Studied US breast cancer (BC) subtypes (2000–2021).
  • Incidence: Ductal (79.1%), lobular (10.9%), mucinous (2.8%), medullary (0.7%).
  •  Survival: Metastatic BC (APC 3.5%), lobular (HR 1.58) had worse outcomes.
  • Need targeted interventions for tougher subtypes.”

Chalothorn “Sai” Wannaphut, Internal Medicine Resident at the John A. Burns School of Medicine, reshared the post on X, adding:

Honored to contribute to this important study!

Grateful for the guidance of my mentor, Dr. Arya Roy in shaping this work.”

Incidence and survival outcomes of breast cancer subtypes in the United States.

Authors: Sakditad Saowapa, Chalothorn Wannaphut, Jayalekshmi Jayakumar, Ben Ponvilawan, Safa Saadat Afridi, Varsha Gupta, and Arya Mariam Roy.

You can read the full article on Journal of Clinical Oncology.

Incidence and Survival Outcomes of Breast Cancer Subtypes in the United States

More posts featuring Sakditad “Tew” Saowapa.